1,015 filings
Page 10 of 51
SC 13G
ABIO
ARCA biopharma Inc
1 Jun 20
ARCA biopharma / SABBY MANAGEMENT ownership change
2:07pm
8-K
ABIO
ARCA biopharma Inc
1 Jun 20
ARCA Biopharma announces $9.4 million registered
8:27am
8-K
ABIO
ARCA biopharma Inc
28 May 20
ARCA Biopharma announces AB201 development program for treatment of covid-19 ASSOCIATED COAGulopAthy
5:15pm
EFFECT
ABIO
ARCA biopharma Inc
21 May 20
Notice of effectiveness
12:15am
CORRESP
ABIO
ARCA biopharma Inc
18 May 20
Correspondence with SEC
12:00am
UPLOAD
ABIO
ARCA biopharma Inc
14 May 20
Letter from SEC
12:00am
S-3
ABIO
ARCA biopharma Inc
Shelf registration
7 May 20
4:16pm
8-K
ABIO
ARCA biopharma Inc
6 May 20
ARCA Biopharma announces First quarter 2020 financial results AND Provides CorporatE update
4:40pm
10-Q
2020 Q1
ABIO
ARCA biopharma Inc
Quarterly report
6 May 20
4:17pm
8-K
ABIO
ARCA biopharma Inc
4 Mar 20
Entry into a Material Definitive Agreement
4:45pm
S-1
ABIO
ARCA biopharma Inc
IPO registration
26 Feb 20
5:08pm
8-K
ABIO
ARCA biopharma Inc
18 Feb 20
ARCA Biopharma announces FISCAL YEAR 2019 financial results AND Provides CorporatE update
4:36pm
10-K
2019 FY
ABIO
ARCA biopharma Inc
Annual report
18 Feb 20
4:16pm
SC 13G/A
ABIO
ARCA biopharma Inc
13 Feb 20
Beneficial ownership report (amended)
12:00am
SC 13G/A
ABIO
ARCA biopharma Inc
24 Jan 20
ARCA biopharma, Inc.
8:01am
8-K
ABIO
ARCA biopharma Inc
11 Dec 19
Submission of Matters to a Vote of Security Holders
4:15pm
10-Q
2019 Q3
ABIO
ARCA biopharma Inc
Quarterly report
6 Nov 19
4:21pm
8-K
ABIO
ARCA biopharma Inc
6 Nov 19
ARCA Biopharma announces third quarter 2019 financial results AND Provides CorporatE update
4:15pm
DEFA14A
ABIO
ARCA biopharma Inc
25 Oct 19
Additional proxy soliciting materials
5:04pm
DEF 14A
ABIO
ARCA biopharma Inc
Definitive proxy
25 Oct 19
5:03pm